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Phosphoribosylamine (PRA) is the first intermediate in the
common pathway to purines and thiamine and is generated in
bacteria by glutamine phosphoribosylpyrophosphate (PRPP)
amidotransferase (EC 2.4.2.14) from PRPP and glutamine.
Genetic data have indicated that multiple, non-PRPP amido-
transferasemechanisms exist to generate PRA sufficient for thi-
amine but not purine synthesis. Here we describe the purifica-
tion and identificationof an activity (present in bothEscherichia
coli and Salmonella enterica) that synthesizes PRA from ribose
5-phosphate and glutamine/asparagine.Apurification resulting
in greater than a 625-fold increase in specific activity identified
8 candidate proteins. Of the candidates, overexpression of
AphA (EC 3.1.3.2), a periplasmic class B nonspecific acid phos-
phatase, significantly increased activity in partially purified
extracts.NativepurificationofAphAto>95%homogeneitydeter-
mined that the periplasmic L-asparaginase II, AnsB (EC 3.5.1.1),
co-purified with AphA andwas also necessary for PRA formation.
The potential physiological relevance of AphA and AnsB in con-
tributing to thiamine biosynthesis in vivo is discussed.
In bacteria, phosphoribosylamine (PRA)4 is the first interme-
diate in the biosynthetic pathways for purines and the pyrimi-
dine moiety of thiamine (1–4) (Fig. 1). Glutamine-PRPP
amidotransferase (E.C. 2.4.2.14), the product of the purF gene
in Salmonella enterica (and Escherichia coli), catalyzes the syn-
thesis of PRA from PRPP and glutamine. Strains lacking PurF
have the expected nutritional requirement for purines; how-
ever, under some growth conditions S. enterica strains lacking
PurF are able to grow in the absence of thiamine (5, 6). Genetic
and biochemical studies have demonstrated this growth
reflects the existence of a PurF-independent mechanism(s) to
generate PRA that is utilized by subsequent purine and thia-
mine enzymes to generate the hydroxymethyl pyrimidine moi-
ety of thiamine (7, 8). However, PRA generated in the absence
of PurF is not sufficient to satisfy the cellular requirement for
purines.
An inability to obtain mutants devoid of PRA formation sug-
gests multiple activities that can generate this metabolite. PRA
could be generated by a side reaction(s) of enzyme(s) involved
in other metabolic pathways, redistribution of metabolic flux,
or a combination of the two. Results implicating the anthrani-
late synthase-phosphoribosyltransferase complex (TrpDE, EC
4.1.3.27, EC 2.4.2.18), required in tryptophan biosynthesis in
the synthesis of PRA (9, 10), are consistent with this scenario.
Genetic studies have shown that a functional oxidative pentose
phosphate pathway is required for at least one route of PRA bio-
synthesis independent of PurF and distinct from the Trp enzymes
(6, 9, 11). Nutritional studies were consistent with a role of the
oxidative pentose phosphate pathway in contributing ribose
5-phosphate (R5P) for PRA synthesis (Fig. 1) (6, 11, 12).
The study described here was initiated to test the hypothesis
that a PRA-forming activity utilizing R5P as a substrate is pres-
ent in bacterial cells. Here we describe the identification and
purification of a PRA-forming activity present in E. coli and
S. enterica which converts R5P and asparagine or glutamine to
PRA. Purification of this activity fromcrude extract determined
that it required two proteins encoded by aphA and ansB.
EXPERIMENTAL PROCEDURES
Medium and Chemicals—Culture media supplies were
obtained from Difco. Glutamine, asparagine, glycine, ribose
5-phosphate, PRPP, magnesium acetate, ammonium chloride,
ATP, EDTA,-mercaptoethanol, phenylmethanesulfonyl fluo-
ride, protamine sulfate, DNase I (EC 3.1.21.1), and lysozyme
(EC 3.2.1.17) were obtained from Sigma-Aldrich. KCl, sucrose,
MgCl2, Tris base, methanol, and pyridine were from Fisher.
K2HPO4, KH2PO4, and ammonium sulfate were obtained from
Mallinckrodt Baker (Phillipsburg,NJ). [1-14C]Glycinewas from
PerkinElmer Life Sciences. DEAE-Sepharose Fast Flow and all
chromatography resins were obtained from Amersham Bio-
sciences. Cellulose-polyethyleneimine plates were fromSelecto
Scientific (Suwanee, GA). Ultrafiltration YM membranes were
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fromAmicon (Beverly, MA). All restriction enzymes used were
from Promega (Madison, WI). AnsB (EC 3.5.1.1) from E. coli
(catalog number A4887) was obtained from Sigma-Aldrich.
Strains, Cell Growth, Extract Preparation—Strain DM1293
(E. coli, purF::Tn10) was grown in Luria-Bertani broth in a
16-liter batch fermentor. Strain DM1936 (S. enterica, purF2085)
was grown in nutrient broth in a 16-liter batch fermentor. The
mediumwas inoculated with 1 liter of an overnight culture and
incubated at 37 °C with aeration for 12 h. Cells (88 g) were
harvested by centrifugation at 4 °C, washed twice with buffer A
(0.05 M potassium phosphate buffer, pH 7.5, containing 5 mM
-mercaptoethanol and 1 mM phenylmethanesulfonyl fluo-
ride), and resuspended in 200 ml of the same buffer. The cells
were disrupted using a French pressure cell at 104 kPa. Clar-
ified cell-free extract was obtained by centrifugation at
23,700 g for 45min at 4 °C.When grown on a smaller scale,
media were inoculated with a nutrient broth overnight cul-
ture and incubated at 37 °C with agitation until full cell den-
sity was achieved. Cell-free extracts were then generated as
described above.
Assay for PRA Formation—A PRA-forming activity assay
described for glutamine-PRPP amidotransferase (4, 13) was
modified to optimize sensitivity. PRA synthesis was assayed in
50mM potassium phosphate buffer, pH 8.0, in the presence of 6
mM magnesium acetate, 2.5 mM ATP, 2 mM [14C]glycine (26
nCi), a pool of amino acids containing equal concentrations (6
mM) of glutamine, asparagine, and 2 g of glycinamide ribonu-
cleotide (GAR) synthetase. Reactions were started by the addi-
tion of R5P (13 mM final concentration) and incubated at 37 °C
for 4 h. Radiolabeled GAR and glycine were separated by thin-
layer chromatography (TLC) on polyethyleneimine-cellulose
using a methanol:pyridine:water system (20:1:5). The position
of radioactive spots was detected using aCyclone Storage Phos-
phor System (Packard Instrument Co.), and their identity was
confirmed with standards.
Protein Purification
GAR Synthetase (PurD)—GAR synthetase was purified to
95% homogeneity from E. coli strain DM1295 (purF::Tn10/
pJS187). Plasmid pJS187 provides for the overexpression of
GAR synthetase (14). PurD protein was purified as described
using ammonium sulfate fractionation, ion exchange chroma-
tography (DEAE resin), and size exclusion chromatography
(14). The activity of the purified protein was assayed by moni-
toring [14C]GAR production from [14C]glycine and chemically
synthesized PRA (4, 13, 15). Alternatively, PurDwas purified by
affinity chromatography using the IMPACTCNKit (New Eng-
landBiolabs, Ipswich,MA). AC-terminal intein tagwas created
by amplifying the open reading frame of purD from S. enterica
LT2 chromosomal DNA by PCR using Platinum Pfx DNA po-
lymerase (Invitrogen). This construct was cloned into the NdeI
and SmaI sites of the plasmid pTYB2.Overexpression and puri-
fication of the protein were performed as recommended by
the manufacturer and resulted in a native protein containing
a single additional glycine at the N-terminal end. Prepara-
tions of PurD purified by either method were used inter-
changeably with no affect on the ability to detect PRA-form-
ing activity.
PRA-forming Activity—Nucleic acids were precipitated by
the addition of protamine sulfate to the clarified cell-free
extract at a final concentration of 0.1% with constant stirring
over 10 min. The solution was then stirred for an 30 additional
min and centrifuged at 23,700  g for 20 min. A two-step salt
precipitation was performed. The clarified cell-free extract was
FIGURE 1. Pathway schematics; biosynthetic pathway for purine and thiamine synthesis. Some purine gene products are indicated above the reactions
they catalyze. The proposed substrates for the alternative PRA synthesis are R5P and an unknown amino donor. AIR, aminoimidazole ribotide; HMP-PP,
4-amino-5-hydroxymethylpyrimidine pyrophosphate; THZ-P, 4-methyl-5-(-hydroxyethyl)thiazole phosphate.
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brought to 35% saturation by the addition of solid ammonium
sulfate with constant stirring for 30min. The solution was then
stirred for 30 additional min and centrifuged at 23,700 g for
30min. The same procedure was used in a second precipitation
step performed at 70% saturation. The supernatant at 70% sat-
uration was discarded, and the precipitate was resuspended in
buffer A (0.05 M potassium phosphate buffer, pH 7.5, contain-
ing 5 mM -mercaptoethanol, and 1 mM phenylmethanesulfo-
nyl fluoride) and dialyzed against the same buffer. The dialyzed
fraction was applied at a flow rate of 2 ml/min to a DEAE ion
exchange column (200-ml column volume) equilibrated with
buffer A. The column was washed with two column volumes
(CV) of buffer A, and all PRA-forming activity was found to be
in the flow-through and wash fractions. These fractions were
pooled and concentrated using a 30-kDa cut-off Amicon ultra-
filtration membrane. The concentrated fraction was applied at
a flow rate of 0.5ml/min to aHiLoad Superdex 75 size exclusion
column (24-ml CV) equilibrated with buffer A containing 100
mM KCl; 1-ml fractions were collected and assayed for PRA-
forming activity. The active fractions were applied at a flow rate
of 2ml/min to aMonoQ (strong ion exchange) column (8ml of
CV) equilibrated with buffer A. After a 2-CV wash with buffer
A, a linear gradient from 0 to 1 M KCl was used to elute the
proteins bound to the column; 1-ml fractions were collected
throughout the wash and elution. After dialyzing against buffer
A, the fractions were tested for PRA-forming activity and
stored at 4 °C.
An alternative step was used interchangeably with the DEAE
column chromatographic step. In this alternative 100 cubic
centimeters of unpackedDEAE resin equilibratedwith buffer A
was mixed with the dialyzed fractions, and the suspension was
placed on ice for 10min. Trial experiments determined that this
batch elution protocol resulted in purification of the PRA-
forming activity with the same efficiency as collecting the flow-
through from standard column chromatography. The superna-
tant was removed by filtration. The resin was washed with an
additional 200 ml of buffer A, which was then pooled with the
200-ml supernatant and concentrated using a using a 30-kDa
cut-off Amicon ultrafiltration membrane and applied to a
Superdex 75 size exclusion column (see above).
AphA—Strain DM10089 (purF2085 ansB1::Kan pSU-aphA)
was grown in nutrient broth with chloramphenicol (20 g/ml)
in a 16-liter batch fermentor, and the cells were collected by
centrifugation. Proteins from the periplasmic space were iso-
lated using a modified spheroplasting technique (16). The
resulting protein preparation was subjected to the purification
scheme described for the PRA-forming activity. SDS-PAGE
protein bands were visualized by staining with a Silver Stain
Plus kit from Bio-Rad, and the protein prep was determined to
be95% pure after passage through a Superdex 75 size exclu-
sion column (data not shown). The protein prep was then
stored at 4 °C for twomonths or frozen and stored at80 °C for
future use.
Protein Quantification andManipulation
Protein was quantified by the method of Bradford (17) or by
using a BCA protein assay kit (Pierce). Ultrapure bovine serum
albuminwas used to generate a standard curve.After SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE), protein bands
were visualized by staining with either (a) 40:55:5:0.05 ethanol:
water:acetic acid:Coomassie G-250 and distained in 40:55:5
ethanol:water:acetic acid or (b) silver using a Silver Stain Plus
kit from Bio-Rad.
Analysis of Candidate Genes
Candidate genes were amplified from S. enterica LT2 chro-
mosomal DNA by PCR using Platinum Pfx DNA polymerase
(Invitrogen) with the primers shown in Table 1. The resulting
PCR products were purified and cloned into the multicloning
site of pSU19 (18). Plasmids were electroporated into E. coli
strain DH5 and screened for vectors containing inserts. Con-
structs containing the cloned genes under the control of the lac
promoter were confirmed by sequence analysis and introduced
into S. enterica strain DM1936.
Candidate proteins were partially purified from cell-free
extracts of strains overexpressing them. Cells (3 g) were
resuspended in buffer A (6 ml) with 2 mg/ml lysozyme and 1
mg/ml DNase before disruption with a French pressure cell at
104 kilopascals. Clarified cell-free extract was obtained by cen-
trifugation at 39,000  g for 30 min at 4 °C. The clarified cell-
free extract was at 65 °C for 5min, centrifuged at 39,000 g for
45min at 4 °C, and run by gravity feed over two DEAE columns
(6-ml CV) equilibratedwith buffer A running in tandem at 4 °C.
A 6-ml wash was combined with the flow-through fraction and
concentrated with a 30-kDa cut-off Amicon ultrafiltration
membrane.
RESULTS
Optimization of in Vitro Assay for PRA Formation—Past pro-
tocols for PRA-formation have utilized a coupled reaction with
glycinamide ribotide synthetase (PurD) in which the substrate
([14C]glycine) is separated from the product ([14C]GAR) by ion
exchange chromatography based on the charge conferred by
the phosphate group in GAR (4). Use of this assay in crude
cell-free extracts was hampered by nonspecific phosphatases
that partially converted GAR to GARs and, thus, decreased the
sensitivity of the assay. Because the activity of interest was
expected to be weak, a TLC system using a mobile phase of
methanol/pyridine/water (20:1:5) on polyethyleneimine-cellu-
TABLE 1
Primers used in this study
Plasmida Primers used to amplify insert
pIR-mdh 5-GCCTGTGTCACGCCTCGCAAATAA-3
5-GCGACCTGCATGTGCCTGTTGG-3
pIR-mdoG 5-CACGTATTCTCAGATTTTTCACCT-3
5-CGCGAGTAAGTCCGATGCT-3
pIR-ydcG 5-CTGAAGAATGCTGCGTGAGG-3
5-GAGCAGCACTTAATAAACCCAGAG-3
pSU-aphA 5-GTCGACCCGTTACTGGCGTTATGGTC-3
5-GGATCCGTGCAGCAAGTCTGGAAAAG-3
pSU-cpdB 5-CTGCAGGGAACGATATCGGGTTTCAC-3
5-GGATCCCGGGAACGTTTATCAGATGG-3
pSU-ansB 5-CTGCAGTAAACAATGGCGCAGATCG-3
5-GGATCCGTGCGAGAGGTCTTCCAAAG-3
pSU-yghA 5-GAGAGTCGACGAATACGGGCGAAGCATAAG-3
5-CAGAGGATCCAAGTGGCGCCTTGCTTAAC-3
pSU-talA 5-GAGACTGCAGGCCTGTCTGCTATGCTTTTTG-3
5-GAGAGGATCCCATTGGCAAGGTCTTTACGG-3
a For all plasmids, pSU19 (Cmr) was used.
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lose plates was used to separate unincorporated [14C]glycine
from the [14C]GAR/[14C]GARs.
Initial screens for PRA-forming activity were preformed in
S. enterica and E. coli cell-free extracts lacking glutamine-PRPP
amidotransferase. Either PRPP or R5P was provided as the car-
bon backbone donor and a pool of amino acids containing glu-
tamine, asparagine, alanine, and valine (each at 6 mM) as the
potential source of the amino group. Subsequent experiments
determined that glutamine and asparagine were equally profi-
cient as amino donors, and no other amino acid allowed PRA
formation. Control experiments determined PRA was formed
in the absence of extract (data not shown) if R5P was provided
to the Tris-HCl buffer used in previous work (pH 8.0, 100 mM)
(4). Because PRA can be chemically synthesized from R5P and
ammonia, this nonenzymatic formation was attributed to small
amounts of ammonia in the buffer (15, 19). Additional buffers
(HEPES-NaOH,Clark andLubsKH2PO4-NaOH, pH. 8, 50mM)
were discarded for a similar reason or because the (PurD) activ-
ity was negatively affected. Potassiumphosphate buffer, pH 8.0,
was found to produce negligible background PRA formation
and was used in subsequent experiments.
Initial Characterization of a PRA-forming Activity in Cell-
free Extracts Lacking PurF—Dialyzed cell-free extracts from
S. enterica and E. coli strains lacking glutamine-PRPP amido-
transferase failed to support synthesis of PRA from either R5P
or PRPP, glutamine, and asparagine. It was subsequently found
that synthesis of PRA from R5P, glutamine, and asparagine was
detectable after the cell-free extract had interacted with an
anion exchange resin (DEAE, pH 7.5) and/or was subjected to
65 °C for 5min.Detection of this activity is shown in Fig. 2. Data
in Fig. 2A show that in the presence of fractionated extract,
formation of GAR was detectable when R5P (lane 2), but not
PRPP (data not shown), was provided with amino acids. The
PRA-forming activity was decreased when heated at 98 °C for 5
min (lane 3) and retained after dialysis (lane 4). Furthermore,
the activity was unaffected by treatment with either RNase or
DNase (data not shown). Accumulation of GAR was propor-
tional to the time of assay incubation up to 4 h, as shown by data
from a representative experiment in Fig. 2B. Data in Fig. 2C
show that GAR synthesis was proportional to protein up to 15
g, after which a plateau was reached. The data in Figs. 2, B and
C, are from a representative experiment, and GAR concentra-
tion was determined from a linear curve of radiolabeled glycine
generated under visualization conditions.
Inability to detect PRA-forming activity in crude cell-free
extracts before fractionation suggested the presence of an
inhibitory compound. Subsequent experiments determined the
target of inhibition was the PurD reaction, and it was not fur-
ther characterized.
Purification of PRA-forming Activity—PRA-forming activity
was followed during fractionation of an E. coli strain lacking
glutamine-PRPP amidotransferase (DM1293 (E. coli purF77::
Tn10)). A purification protocol was implemented and is sum-
marized in Table 2. A typical purification used 250 ml of cell-
free extract (8 mg/ml) fractionated by precipitation with
ammonium sulfate as described under “Experimental Proce-
dures.” The proteins precipitated at 70% saturation were resus-
pended in buffer A and dialyzed against the same buffer. Ion
exchange chromatography was performed on the dialyzed frac-
tions (200ml). PRA-forming activitywas detectable at this stage
in the flow-through fraction, and this activitywas set to be 100%
for subsequent yield determination.
After interaction with the DEAE resin, the PRA-forming
activity was further purified and concentrated by passage
through a 30-kDa cut-off Amicon ultrafiltrationmembrane fol-
lowed by size exclusion chromatography and ion exchange
chromatography as described under “Experimental Proce-
dures.” Data in Table 2 indicates a 625-fold final purification
was achieved.
Proteins in the active fractions from the purification were
visualized after separation on SDS-polyacrylamide gel. The
FIGURE 2. PRA-forming activity in a partially purified extract from an E.
coli purFmutant. A, synthesis of PRA as a function of [14C]GAR production.
Reactions were performed as described under “Experimental Procedures”
adding an amino acid pool (glutamine and asparagine) and R5P as sub-
strates in the absence (lane 1) and presence of a fresh (lane 2), boiled (lane
3), or dialyzed (lane 4) partially purified cell extract. After incubation at
37 °C for 4 h, radiolabeled [14C]GAR and [14C]glycine were separated on
polyethyleneimine-cellulose using a methanol/pyridine/water (20:1:5)
solvent system. B, GAR synthesis versus time. GAR synthesis from R5P and
an amino acid pool in the presence (f) and absence () of the partially
purified extract (10 mg total protein). C, synthesis of GAR in the presence
of increasing amounts of protein after 4 h of incubation at 37 °C.
TABLE 2
Purification of PRA-forming activity
PRA synthesis fromR5P, glutamine, and asparaginewas determined to be a function
of radiolabeled [14C]GAR production.
Purification step Specificactivity Purification Yield
Unitsb/mg
of protein
%
Cell-free extract NDa
(NH4)2SO4 precipitation ND
DEAE ion exchange chromatography
(flow-through)
506 1
Superdex 75 size exclusion
chromatography
10,848 22 68
Mono Q ion exchange chromatography 316,492 625 89
aND, none detected.
b Arbitrary units detected by the Cyclone Storage Phosphor System.
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fraction from the Mono Q column contained multiple protein
bands (data not shown). Final active fractions from three inde-
pendent purifications and an inactive fraction from the final
column were sent toMidwest Bio Services (Overland Park, KS)
for in-gel extraction and mass spectrometry analysis. Table 3
summarizes the proteins identified in all active fractions and
not present in the inactive fraction.
Partially Purified AphA Has PRA-forming Activity—Genes
encoding each of the eight proteins described in Table 3 were
amplified from S. enterica and cloned into a pSU19 multicopy
plasmid. The resulting constructs were introduced into the
S. enterica strain DM1936 (purF2085). Cell free extracts from
the resulting strains were subjected to partial purification and
assayed for PRA-forming activity. Of the eight strains, two had
more PRA synthesis than the parental strain (Fig. 3). The strain
overexpressing AphA (lane 1) and the strain overexpressing
AnsB (lane 2) were found to have increased PRA formation
relative to the control strain DM1936 (lane 4). Purified AnsB
was purchased (Sigma) and tested for its ability to make PRA.
Although AnsB allowed PRA formation (lane 3), two points
were noted. First, 10 g of AnsB allowed less PRA formation
than crude extract of the AphA-overproducing strain. Second,
as an asparaginase, AnsB produces NH3 and, thus, PRA forma-
tion is expected to be at least partially due to the nonenzymatic
combination of ammonia and R5P (15).
AphA and AnsB Are Required for PRA-forming Activity—
AphAwas purified from strain DM9518 (purF2085 pSU-aphA)
to 95% homogenicity and tested for PRA-forming activity.
Ten micrograms of this protein preparation generated more
PRA than the partially purified extract from DM9518 (data not
shown), although there was a noticeable contaminating protein
band of approximately the size of the AnsB protein (35 kDa).
To address the possible contribution of AnsB to the detected
PRA-forming activity, a strain lacking AnsB and PurF activities
was generated. Plasmid pSU-aphA was moved into this strain
to create DM10089 (purF2085 ansB1::Kan pSU-aphA). AphA
was then purified after overexpression in the ansB mutant
background and found to have no PRA-forming activity. Addi-
tional protein preparations confirmed that AphA is not suffi-
cient to catalyze PRA formation.
Data in Fig. 4 showed that although neither 10 g of AphA
(lane 1) or AnsB (lane 2) allowed significant PRA formation, a
mixture of the two proteins did. In the presence of less than
molar amounts of AnsB, AphA was able to generate significant
amounts of PRA. From these data it was concluded that the
PRA-forming activity purified from crude extracts was due to a
complex involving the periplasmic proteins AphA and AnsB.
Physiological Role of AphA and AnsB in Thiamin Bio-
synthesis—Results described here showed that AphA andAnsB
have the ability to produce PRA in vitro. Strain DM10259
(purF2085 ansB1::Kan aphA15::Cm) was constructed and ana-
lyzed for growth under various conditions known to allow
PurF-independent PRA formation. In all growth conditions
tested, the strain lacking ansB and aphA grew as well as the
parental purFmutant, indicating this PRA-forming activity was
not essential for growth. When aphA or ansB was placed in
multicopy, neither allowed a purFmutant strain to grow in the
absence of thiamine under non-permissive conditions (data not
shown).
DISCUSSION
This study describes the identification and purification of a
cellular activity from both E. coli and S. enterica that synthe-
FIGURE 3. PRA-forming activity in partially purified protein extracts. PRA
formation as a function of radiolabeled [14C]GAR from R5P, asparagine, and
glutamine using 10gof DM9518 (purFpSU-aphA) (lane 1), 10gof DM9584
(purF pSU-ansB) (lane 2), 10 g of pure AnsB from Sigma (lane 3), 10 g of
DM1936 (purF) (lane 4), and no protein control (lane 5). After incubation at
37 °C for 4 h, radiolabeled [14C]GAR and [14C]glycine were separated by TLC,
and the [14C]GAR spots are shown.
FIGURE 4. Formation of PRA from AphA and AnsB. PRA formation using
purified protein as a function of radiolabeled [14C]GAR from R5P, asparagine,
and glutamine using 10g of AphA (lane 1), 10 g of AnsB (lane 2), 0.1 g of
AnsB (lane 3), 10g AphA plus 1.0g of AnsB (lane 4), 10g of AphA plus 0.1
gofAnsB (lane 5), 10gofAphAplus 10ngAnsB (lane 6), 10gofAphAplus
5.0 ngAnsB (lane 7), 10gof AphAplus 1.0 ngof AnsB (lane 8), andnoprotein
control (lane 9). After incubation at 37 °C for 4 h, radiolabeled [14C]GAR and
[14C]glycine were separated by TLC, and the [14C]GAR spots are shown.
TABLE 3
Identification of potential PRA-forming enzymes by mass spectrometry analysis
Gene Straina Gene productb Size Function
kDa
mdoG DM9380 Putative periplasmic glycoprotein 57 Periplasmic glucans biosynthesis, addition of branches to linear glucan
backbone
ydcG DM9831 Putative periplasmic glycoprotein 61 Periplasmic glucans biosynthesis
mdh DM9379 Malate dehydrogenase 32 Interconversion of L-malate and oxaloacetate
talA DM9652 Transaldolase A 35 Reversible 3-carbon ketol unit transfer from sedoheptulose 7-phosphate
(P) to glyceraldehyde 3-P to form erythrose 4-P and fructose 6-P
yghA DM9615 Hypothetical oxidoreductase NAD(P) binding 31 Belongs to the short-chain dehydrogenases/reductases (SDR) family
cpdB DM9520 2,3-Cyclic nucleotide 2-phosphodiesterase 70 Salvage of nucleosides and nucleotides (interconversion)
ansB DM9584 Periplasmic L-asparaginase II 35 Hydrolysis of asparagine to aspartic acid and ammonia
aphA DM9518 Periplasmic class B phosphatase/phosphotransferase 25 Non-specific acid phosphatase/phosphotranserase
a purF2085 strain with gene cloned into pSU19.
b At least two different peptides matching the identified protein were detected by mass spectrometry.
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sizes PRA.Data herein showed that AphA, a periplasmic class B
nonspecific acid phosphatase/phosphotransferase (EC 3.1.3.2),
in combination with submolar ratios of the periplasmic L-as-
paraginase II, AnsB (EC 3.5.1.1), can produce PRA from R5P
and either asparagine or glutamine in vitro. Titration experi-
ments determined that (at pH 7.5) optimal PRA-formation
occurred when AphA and AnsB were provided at a 13:1 molar
ratio. We suggest that AphA binds R5P and catalyzes the for-
mation of PRA when presented with the ammonia released by
hydrolysis of asparagine or glutamine by AnsB.
Based on the enzymes involved, a scenario in which either
one could produce PRA is feasible. Although AphA has been
characterized primarily for its ability to dephosphorylate
mononucleotides and various other phosphomonoesters, the
enzyme has been shown to catalyze dephosphorylation of R5P.
This finding indicates that the enzyme can bind R5P, although
it is acted onwith a relatively low catalytic efficiency (Kcat/Km
5.0 103 M1 s1, pH 6) (20). At physiological pH the protein
exhibits suboptimal activity, potentially decreasing this cata-
lytic efficiency further, raising the possibility that R5P could
bind in the active site without dephosphorylation occurring. In
this scenario, AphA could serve to concentrate R5P, allowing
PRA formation to occur when ammonia is present. Because
AnsB hydrolyzes both asparagine and glutamine optimally at
pH 7.5 (21), a simple scenario suggests that AnsB produces
ammonia that allows nonenzymatic formation of PRA in the
presence of R5P (15).
Althoughmore complex scenarios for the generation of PRA
by the individual enzymes could be imagined, several observa-
tions suggested AphA and AnsB together were responsible for
the PRA production detected herein. First, AphA and AnsB
co-purified through several chromatographic steps, consistent
with at least a loose association of the two proteins. The fact
that both enzymes are located in the periplasm is consistent
with this interpretation. Second, the amount of PRA formed
with the addition of both proteins was noticeably more than
that generated byAphAevenwith excess ammonia.We suggest
a model in which PRA is formed in the active site of AphA. By
this scenario R5P would occasionally bind the AphA enzyme,
blocking the active site due to the poor catalytic activity of the
enzyme with this substrate. This association would remain
until the glutaminase/asparaginase releases ammonia in close
proximity, perhaps allowing the interaction of R5P and ammo-
nia, resulting in PRA formation. The inability of PRPP to allow
PRA formation could be due to the binding specificity of AphA.
Alternatively, the inability of PRPP to participate in the reaction
could support the nonenzymatic mechanism proposed. If PRA
is easily released from the enzyme, this could benefit the orga-
nism by restoring the availability of the active site for mononu-
cleotide dephosphorylation. Testing this model will require
additional kinetic analyses in vitro.
Although AphA/AnsB could synthesize PRA in vitro, a con-
dition where these proteins were essential for thiamine biosyn-
thesis in vivo was not identified. Localization studies showed
that AphA is present in the cytoplasm in addition to its pre-
dominant location in the periplasm (22); thus, is it rational to
suggest some PRA is generated by the mechanism described
herein. Previous work in our laboratory has emphasized the
multiple inputs to PRA formation (9, 10, 23). In all cases sepa-
rate from that described here, these inputs have been identified
using sensitive in vivo genetic analyses. The work described
here emphasizes that the cell has additional capacity to gener-
ate metabolites that may not be apparent by only addressing
activities essential for growth. Furthermore, there is not a good
way of determining that the appropriate condition to detect
essentiality has been tested.
The robustness of cellular metabolism predicts that multiple
inputs to many (if not all) metabolites will exist. Such overlap
can be considered to occur by evolutionary pressure or simply
be the natural result of biochemical reactions that involve com-
pounds of similar structure. Regardless of the evolutionary
questions, from the perspective of understanding themetabolic
network in the cell it is important to define not only reactions
that are easily recognized as essential for growth but the poten-
tial for robustness provided by minor reactions. Based on the
work herein, AphA is component of the cell that can be probed
with in vitro biochemical approaches to generate a better
understanding of metabolic robustness with respect to PRA
formation.
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